The new system uses AI-driven analytics, IoT sensors, and network connectivity to eradicate hazards in private rooms and public spaces by targeting a range of pathogens.
EPIC iO, a pioneering firm in the field of applied Artificial Intelligence and Internet of Things (AIoT), has announced a new deployment in an unlikely place: Ronald McDonald House Charities. The innovative EPIC iO AURA™ automated disinfection system at Ronald McDonald House Charities (RMHC of GC) of Greater Charlotte will help keep families of local patients safe during treatments.
How does it use AI?
EPIC iO AURA™, a biosecurity device compact enough to fit in a briefcase, operates by continuously monitoring a room’s air and releasing micro-doses of FDA-approved ozone to inactivate pathogens. This mechanism offers a superior alternative to traditional disinfectants, which often rely on chemical sprays and foggers. The EPIC iO AURA™ solution ensures even disinfection throughout the room, reaching hidden surfaces, and is both safer and easier to use.
The EPIC iO AURA™ system uses AI-driven analytics, IoT sensors, and network connectivity to eradicate hazards in private rooms and public spaces by targeting a range of pathogens—from Candida auris and MRSA to SARS-CoV-2 and Influenza. The introduction of this advanced disinfection solution has already yielded promising early results, enhancing the safety and comfort of the guest families and adding a layer of assurance.
Helping Ronald McDonald House improve health safety
Ronald McDonald House provides a home-like environment for families with children undergoing medical treatment locally. EPIC iO’s cutting-edge disinfection system, supporting RMHC’s mission, significantly boosts environmental health for these families, particularly the children, who are often immunocompromised and, therefore, more susceptible to various pathogens.
Those close to the project praised the system’s impact, emphasizing its crucial role in minimizing the risk of surface-borne diseases and elevating the guests’ sense of security. The deployment will help improve the peace of mind of families as their loved ones undergo treatments during potentially lengthy stays in healthcare settings locally.
This partnership could signal new ways healthcare researchers and industries can work together to provide holistic solutions for patient outcomes. By streamlining the health monitoring of those in contact with immunocompromised patients, healthcare settings can lessen the impact of outside contaminants while ensuring patients have the close support of their loved ones.